Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes

Gut

Volumn 62, Issue 9, 2013, Pages 1328-1339

  Ishiwatari, Hirotoshi ^a   Sato, Yasushi ^a   Murase, Kazuyuki ^a   Yoneda, Akihiro ^b   Fujita, Ryosuke ^b   Nishita, Hiroki ^b   Birukawa, Naoko Kubo ^b   Hayashi, Tsuyoshi ^a   Sato, Tsutomu ^a   Miyanishi, Koji ^a   Takimoto, Rishu ^a   Kobune, Masayoshi ^a   Ota, Shigenori ^a   Kimura, Yasutoshi ^a   Hirata, Koichi ^a   Kato, Junji ^a   Niitsu, Yoshiro ^b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 CARBOXYFLUORESCEIN; CERULETIDE; CHAPERONE; COLLAGEN; DIBUTYLTIN DICHLORIDE; HYDROXYPROLINE; LIPOSOME; PROTEIN GP46; RECEPTOR; RETINOL; RETINOL BINDING PROTEIN RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AZAN MALLORY STAINING; CELLULAR DISTRIBUTION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GENETIC TRANSDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MALE; METABOLIC INHIBITION; NONHUMAN; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STAINING;

CHRONIC PANCREATITIS; FIBROSIS; PANCREATIC FIBROSIS;

ANIMALS; CERULETIDE; COLLAGEN; FIBROSIS; GASTROINTESTINAL AGENTS; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOSOMES; MALE; MODELS, ANIMAL; ORGANOTIN COMPOUNDS; PANCREAS; PANCREATITIS, CHRONIC; RATS; RATS, INBRED LEW; RATS, WISTAR; RNA, SMALL INTERFERING; TREATMENT OUTCOME; VITAMIN A; VITAMINS;

EID: 84881544147     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301746     Document Type: Article

References (26)

1. Bachem MG, Schneider E, Gross H, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998;115:421-32.
2. Schneider E, Schmid-Kotsas A, Zhao J, et al. Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol 2001;281:C532-43.
3. Shimizu K, Shiratori K, Kobayashi M, et al. Troglitazone inhibits the progression of chronic pancreatitis and the profibrogenic activity of pancreatic stellate cells via a PPARgamma-independent mechanism. Pancreas 2004;29:67-74. (Pubitemid 38857269)
4. Yamada T, Kuno A, Masuda K, et al. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats. J Pharmacol Exp Ther 2003;307:17-23. (Pubitemid 37151887)
5. Kuno A, Yamada T, Masuda K, et al. Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats. Gastroenterology 2003;124:1010-19. (Pubitemid 36389804)
6. Sato Y, Murase K, Kato J, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008;26:431-42. (Pubitemid 351501817)
7. Buchholz M, Kestler HA, Holzmann K, et al. Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med 2005;83:795-805. (Pubitemid 41407863)
8. Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43:128-33. (Pubitemid 28335501)
9. Williams EJ, Benyon RC, Trim N, et al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 2001;49:577-83. (Pubitemid 32896990)
10. Inoue M, Ino Y, Gibo J, et al. The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:e64-70.
11. Merkord J, Jonas L, Weber H, et al. Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas 1997;15:392-401. (Pubitemid 27525636)
12. Elsasser HP, Haake T, Grimmig M, et al. Repetitive cerulein-induced pancreatitis and pancreatic fibrosis in the rat. Pancreas 1992;7:385-90.
13. Puig-Divi V, Molero X, Salas A, et al. Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts. Pancreas 1996;13:417-24. (Pubitemid 26357304)
14. Merkord J, Weber H, Jonas L, et al. Influence of ethanol on long-term effects of dibutyltin dichloride (DBTC) in pancreas and liver of rats. Hum Exp Toxicol 1998;17:144-50. (Pubitemid 28171284)
15. Yamamoto M, Otani M, Otsuki M. A new model of chronic pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 2006;291:G700-8. (Pubitemid 44511687)
16. Tsuchitani M, Saegusa T, Narama I, et al. A new diabetic strain of rat (WBN/Kob). LabAnim 1985;19:200-7. (Pubitemid 15071956)
17. Sparmann G, Merkord J, Jaschke A, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997;112:1664-72. (Pubitemid 27181392)
18. Ishibashi T, Zhao H, Kawabe K, et al. Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats. J Gastroenterol 2008;43:79-85. (Pubitemid 351324990)
19. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-49. (Pubitemid 28376157)
20. Weidenbach H, Lerch MM, Turi S, et al. Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis. Digestion 1997;58:50-7. (Pubitemid 27050885)
21. Masamune A, Watanabe T, Kikuta K, et al. Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 2009;7: S48-54.
22. Jain RK. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-9. (Pubitemid 32937367)
23. Hideshima K, Seike J, Mimura S, et al. HSP47 and angiogenic factor expression and its implication for the healing of periosteal defects in the mouse cranium. Oral Med Pathol 2006;11:27-33.
24. Okada H, Inoue T, Kanno Y, et al. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int 2003;64:1722-32. (Pubitemid 37323701)
25. Zhou X, Hovell CJ, Pawley S, et al. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int 2004;24:492-501. (Pubitemid 40484564)
26. Steffensen B, Wallon UM, Overall CM. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 1995;270:11555-66.